Your browser is no longer supported. Please, upgrade your browser.
Settings
ISR IsoRay, Inc. daily Stock Chart
ISR [NYSE]
IsoRay, Inc.
Index- P/E- EPS (ttm)-0.07 Insider Own0.50% Shs Outstand67.39M Perf Week9.97%
Market Cap44.46M Forward P/E- EPS next Y-0.03 Insider Trans165.43% Shs Float66.50M Perf Month76.65%
Income-4.50M PEG- EPS next Q-0.01 Inst Own5.50% Short Float2.30% Perf Quarter112.50%
Sales8.10M P/S5.49 EPS this Y36.80% Inst Trans-5.91% Short Ratio4.54 Perf Half Y54.12%
Book/sh0.10 P/B6.60 EPS next Y50.00% ROA-42.50% Target Price1.02 Perf Year56.76%
Cash/sh- P/C- EPS next 5Y- ROE-54.20% 52W Range0.27 - 0.78 Perf YTD119.93%
Dividend- P/FCF- EPS past 5Y13.30% ROI-68.20% 52W High-15.08% Beta1.95
Dividend %- Quick Ratio3.80 Sales past 5Y11.60% Gross Margin46.60% 52W Low145.19% ATR0.06
Employees43 Current Ratio4.10 Sales Q/Q43.70% Oper. Margin-57.50% RSI (14)71.44 Volatility10.57% 10.98%
OptionableNo Debt/Eq0.03 EPS Q/Q46.80% Profit Margin-55.30% Rel Volume1.04 Prev Close0.65
ShortableYes LT Debt/Eq0.00 EarningsNov 12 AMC Payout- Avg Volume336.95K Price0.66
Recom2.00 SMA2025.91% SMA5064.37% SMA20068.76% Volume349,190 Change2.06%
Nov-09-18Downgrade Maxim Group Buy → Hold
Feb-14-18Reiterated Maxim Group Buy $3 → $2
Nov-10-15Reiterated Maxim Group Buy $5 → $3
Jul-16-14Resumed Maxim Group Buy $3.50 → $5
Apr-02-14Reiterated Maxim Group Buy $1.50 → $3.50
Nov-01-13Initiated Maxim Group Buy $1.50
Mar-17-10Initiated C.K. Cooper Buy $1.70
Aug-21-08Downgrade Ladenburg Thalmann Buy → Neutral
May-14-08Reiterated Ladenburg Thalmann Buy $2 → $1.50
Feb-13-08Reiterated Punk, Ziegel & Co Buy $6.25 → $2
Sep-24-07Initiated Punk, Ziegel & Co Buy $6.25
Dec-09-19 12:06PM  If You Had Bought IsoRay (NYSEMKT:ISR) Stock Five Years Ago, You'd Be Sitting On A 63% Loss, Today Simply Wall St. +13.73%
Dec-04-19 01:23PM  Edited Transcript of ISR earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-19 09:00AM  What Makes IsoRay (ISR) a New Strong Buy Stock Zacks +9.43%
Nov-12-19 06:26PM  IsoRay (ISR) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:05PM  Isoray Announces Record First Quarter Fiscal 2020 Financial Results GlobeNewswire
Nov-05-19 10:32AM  Will IsoRay (ISR) Report Negative Earnings Next Week? What You Should Know Zacks
Nov-01-19 01:15PM  We Think IsoRay (NYSEMKT:ISR) Needs To Drive Business Growth Carefully Simply Wall St.
Oct-31-19 08:13AM  Isoray To Announce First Quarter Fiscal 2020 Financial Results on November 12, 2019 GlobeNewswire
Oct-29-19 08:13AM  Isoray Will Have Prominent Role at American Brachytherapy Societys Annual Prostate Brachytherapy Workshop GlobeNewswire
Sep-30-19 11:06AM  Edited Transcript of ISR earnings conference call or presentation 24-Sep-19 8:30pm GMT Thomson Reuters StreetEvents -5.68%
Sep-27-19 09:00AM  IsoRay (ISR) Upgraded to Buy: Here's What You Should Know Zacks
Sep-26-19 12:51PM  Breakeven On The Horizon For IsoRay, Inc. (NYSEMKT:ISR) Simply Wall St.
Sep-24-19 05:25PM  IsoRay (ISR) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM  Isoray Announces Fourth Quarter and Full-Year Fiscal 2019 Financial Results GlobeNewswire
02:30PM  IsoRay, Inc. to Host Earnings Call ACCESSWIRE
Sep-18-19 08:13AM  A Decade of Data Shows the Value of Isorays Cesium-131 As Prostate Cancer Internal Radiation Therapy Treatment GlobeNewswire +19.74%
Sep-12-19 08:13AM  Isoray To Announce Fourth Quarter and Year End 2019 Financial Results on September 24, 2019 GlobeNewswire
Sep-10-19 08:13AM  Isoray To Spotlight Cesium-131 Advances in Treating Hard to Treat Cancers at the American Society for Radiation Oncology Annual Meeting GlobeNewswire
Aug-21-19 02:14PM  How Much Are IsoRay, Inc. (NYSEMKT:ISR) Insiders Spending On Buying Shares? Simply Wall St.
Aug-13-19 08:05AM  Efficacy of Isorays Cesium Blu Showcased in Recent Studies GlobeNewswire -5.26%
Jun-21-19 11:03AM  Before You Buy IsoRay, Inc. (NYSEMKT:ISR), Consider Its Volatility Simply Wall St.
Jun-12-19 08:13AM  Isoray To Launch The Power of Blu Introducing A New Brand Identity at the American Brachytherapy Societys Annual Meeting GlobeNewswire
May-23-19 10:04AM  Imagine Owning IsoRay (NYSEMKT:ISR) And Trying To Stomach The 81% Share Price Drop Simply Wall St.
May-09-19 07:45PM  IsoRay (ISR) Reports Q3 Loss, Tops Revenue Estimates Zacks +5.23%
06:39PM  IsoRay: Fiscal 3Q Earnings Snapshot Associated Press
04:05PM  Isoray Announces Record Third Quarter Fiscal 2019 Financial Results GlobeNewswire
May-01-19 08:13AM  Isoray To Announce Third Quarter Fiscal 2019 Financial Results on May 9, 2019 GlobeNewswire
Apr-25-19 10:34AM  Will IsoRay (ISR) Report Negative Q3 Earnings? What You Should Know Zacks
Apr-16-19 08:11AM  Isoray Collaborates With Texas Oncology to Fill Void in Training Programs For Next Generation of Brachytherapists GlobeNewswire
Feb-12-19 06:20PM  IsoRay (ISR) Reports Q2 Loss, Tops Revenue Estimates Zacks +5.23%
05:19PM  IsoRay: Fiscal 2Q Earnings Snapshot Associated Press
04:05PM  Isoray Announces Second Quarter Fiscal 2019 Financial Results GlobeNewswire
02:30PM  IsoRay, Inc. to Host Earnings Call ACCESSWIRE
Feb-05-19 10:30AM  IsoRay (ISR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-30-19 08:13AM  Isoray To Announce Second Quarter Fiscal 2019 Financial Results on February 12, 2019 GlobeNewswire
Jan-29-19 08:13AM  Medical University of South Carolina Performs Worlds First Prostate Cancer Surgery Using Blu Build Brachytherapy System GlobeNewswire +8.13%
Dec-17-18 08:13AM  IsoRay Announces the Appointment of Lori Woods As Chief Executive Officer GlobeNewswire
Dec-03-18 08:13AM  IsoRay Names Jonathan Hunt New Chief Financial Officer GlobeNewswire
Nov-26-18 08:40AM  Report: Exploring Fundamental Drivers Behind Micron Solutions, Gentherm, ENSERVCO, IsoRay, Trilogy Metals, and Xtant Medical New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-08-18 07:05PM  IsoRay (ISR) Reports Q1 Loss, Lags Revenue Estimates Zacks -8.02%
06:03PM  IsoRay: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  IsoRay Announces First Quarter Fiscal 2019 Financial Results GlobeNewswire
Oct-24-18 08:13AM  IsoRay To Announce First Quarter Fiscal 2019 Financial Results on November 8, 2018 GlobeNewswire
Sep-25-18 04:21PM  IsoRay: Fiscal 4Q Earnings Snapshot Associated Press
04:05PM  IsoRay Announces Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
07:21AM  When Can We Expect A Profit From IsoRay Inc (NYSEMKT:ISR)? Simply Wall St.
Sep-10-18 08:15AM  IsoRay To Announce Fourth Quarter and Year End 2018 Financial Results on September 25, 2018 GlobeNewswire
Sep-07-18 08:11AM  What You Must Know About IsoRay Incs (NYSEMKT:ISR) Financial Strength Simply Wall St.
Jul-23-18 07:00AM  Free Technical Research on IsoRay and Three More Medical Supplies Equities ACCESSWIRE
Jul-12-18 08:30AM  IsoRay, Inc. Closes $8,250,000 Registered Direct Offering GlobeNewswire -6.06%
Jul-10-18 09:21AM  IsoRay's stock plunges on premarket -leading volume after stock offering MarketWatch -36.45%
08:10AM  Today's Research Reports on Stocks to Watch: Staffing 360 Solutions and IsoRay ACCESSWIRE
Jul-09-18 07:58PM  IsoRay Announces $8.25 Million Registered Direct Offering GlobeNewswire +143.18%
01:52PM  IsoRay Announces FDA Clearance of GammaTile Therapy for the Treatment of Recurrent Brain Neoplasms GlobeNewswire
Jun-19-18 08:00AM  IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO GlobeNewswire
Jun-05-18 08:00AM  IsoRay Announces the Resignation of Chairman and CEO Thomas LaVoy; Industry Veteran Lori Woods Appointed Interim CEO; Mick McCormick Appointed Chairman of the Board GlobeNewswire
May-31-18 08:30AM  IsoRay to Present at the 8th Annual LD Micro Invitational ACCESSWIRE
May-30-18 08:00AM  IsoRay Announces Signing of Research Funding with Ochsner Clinic Foundation to Support Brain Cancer Treatment Research GlobeNewswire
May-25-18 08:17PM  When Will IsoRay Inc (NYSEMKT:ISR) Breakeven? Simply Wall St.
May-17-18 08:30AM  IsoRay, Inc. Discusses Competitive Landscape, FDA Clearance for New Product Line and Growth Drivers in New SNNLive Video Interview with StockNewsNow.com ACCESSWIRE
May-16-18 07:55PM  Want To Invest In IsoRay Inc (NYSEMKT:ISR)? Heres How It Performed Lately Simply Wall St.
08:30AM  IsoRay Announces Participation at the American Urological Associations 2018 Annual Meeting, May 18-21, 2018 GlobeNewswire
May-11-18 08:30AM  IsoRay Announces the First Disposable Delivery System for Custom Intra-operative Strands for Prostate Cancer Treatment GlobeNewswire +28.72%
May-03-18 06:33PM  IsoRay: Fiscal 3Q Earnings Snapshot Associated Press
04:05PM  IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase GlobeNewswire
May-02-18 08:30AM  IsoRay to Present at the 3rd Annual Disruptive Growth & Healthcare Conference hosted by RHK Capital GlobeNewswire
Apr-26-18 08:00AM  IsoRay Announces Third Quarter Fiscal 2018 Earnings Conference Call GlobeNewswire
Apr-24-18 09:05AM  Isoray (ISR) Stock: Circles Back Toward Leadership Position in Treating Prostate Cancer ACCESSWIRE
Apr-19-18 09:00AM  IsoRay to Present at the Planet MicroCap Showcase 2018 on April 25 in Las Vegas, NV ACCESSWIRE
Apr-18-18 08:30AM  IsoRay Announces Preliminary Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Year-over-Year Increase GlobeNewswire
Feb-09-18 05:01AM  IsoRay reports 2Q loss Associated Press
Feb-08-18 04:05PM  IsoRay Announces Second Quarter Fiscal 2018 Revenue of $1.54 Million, 50% Second Quarter-Over-Second Quarter Increase GlobeNewswire
12:30PM  IsoRay, Inc. to Host Earnings Call ACCESSWIRE
08:00AM  IsoRay Announces Study Published in Cureus entitled, Resection Cavity Contraction Effects in the Use of Radioactive Sources (1-25 versus Cs131) for Intra-Operative Brain Implants GlobeNewswire
Feb-06-18 08:39AM  Was IsoRay Incs (NYSEMKT:ISR) Earnings Decline A Part Of Broader Industry Downturn? Simply Wall St.
Jan-31-18 08:00AM  IsoRay Announces Second Quarter Fiscal 2018 Earnings Conference Call GlobeNewswire
Jan-24-18 08:00AM  IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase GlobeNewswire
Jan-09-18 08:00AM  IsoRay Announces Case Report Publication Discussing Focal Radiation Treatment of Brain Metastases with Cesium-131 GlobeNewswire
Jan-08-18 08:00AM  IsoRay Announces Manufacturing and Supply Agreement with GT Medical Technologies for GammaTile Radiation Therapy System GlobeNewswire +5.44%
Dec-26-17 11:41AM  ETFs with exposure to IsoRay, Inc. : December 26, 2017 Capital Cube -5.60%
Dec-07-17 02:06PM  ETFs with exposure to IsoRay, Inc. : December 7, 2017 Capital Cube
Dec-01-17 08:11AM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 1, 2017 Capital Cube
Nov-28-17 08:00AM  IsoRay to Present at the 10th Annual LD Micro Main Event ACCESSWIRE
Nov-16-17 05:14AM  IsoRay reports 1Q loss Associated Press
Nov-14-17 04:02PM  IsoRay Announces First Quarter Fiscal 2018 Financial Results GlobeNewswire
12:00PM  IsoRay, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-17 08:00AM  IsoRay, Inc. Announces the Launch of a Phase II, Multicenter Clinical Trial with Cesium-131 Adjuvant Radiation for Retroperitoneal Sarcoma Delivery System (CARDS Trial) by University of Louisville, Division of Surgical Oncology GlobeNewswire
Nov-08-17 08:00AM  IsoRay Announces First Quarter Fiscal 2018 Earnings Conference Call Marketwired
Nov-05-17 08:11PM  Is There Now An Opportunity In IsoRay Inc (ISR)? Simply Wall St.
Nov-02-17 12:16PM  ETFs with exposure to IsoRay, Inc. : November 2, 2017 Capital Cube
Oct-23-17 10:43AM  ETFs with exposure to IsoRay, Inc. : October 23, 2017 Capital Cube
Oct-12-17 07:30AM  Corporate News Blog - Antares Pharma Sells ZOMAJET(TM) Assets in a Potential $14.5 Million Deal ACCESSWIRE
Oct-11-17 07:40AM  Earnings Review and Free Research Report: AngioDynamics Reported Lower than Expected Quarterly Results ACCESSWIRE
Oct-10-17 11:33AM  ETFs with exposure to IsoRay, Inc. : October 10, 2017 Capital Cube
Oct-05-17 04:26PM  Should You Sell IsoRay Inc (ISR) For This Reason? Simply Wall St.
Oct-04-17 08:54AM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube
Oct-02-17 09:51AM  IsoRay, Inc. :ISR-US: Earnings Analysis: 2017 By the Numbers : October 2, 2017 Capital Cube
Sep-28-17 09:41PM  IsoRay reports 4Q loss Associated Press
08:00AM  IsoRay Announces Fourth Quarter Fiscal 2017 Revenue of $1.37 Million, 22% Fourth Quarter-over-Fourth Quarter Increase PR Newswire
Sep-26-17 08:00AM  IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy (PIB): A Potentially Durable Technique for Salvaging Recurrent Pelvic Malignancies" PR Newswire
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krachon MichaelVP of Sales & MarketingNov 20Buy0.3950,00019,49550,000Nov 21 04:30 PM
Woods Lori ACEONov 15Buy0.3925,0009,745280,000Nov 19 05:04 PM
Cavanagh WilliamChief R&D OfficerNov 15Buy0.3910,0003,90020,000Nov 19 05:01 PM
Woods Lori ACEONov 14Buy0.40125,00049,550255,000Nov 19 05:04 PM
Cline KristaDir. of Operations, SecretaryMay 30Option Exercise0.2621,9005,69422,933Sep 20 05:39 PM